Merrimack Pharmaceuticals (MACK)
5.98
-0.16 -2.61%
NASDAQ
Sep 23, 20:00
Delayed 2m
USD
View All Key Stats
MACK Key Stats
| Income Statement | |
| Revenue (TTM) | 92.82M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.53 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -179.64M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 94.44% |
| Profit Margin (Quarterly) | -150.7% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 772.86M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 7.574 |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | -1.070 |
| Free Cash Flow (Quarterly) | -51.72M |
| Return on Equity (TTM) | 101.3% |
View All MACK News
MACK News
-
WireHeadlineTime (ET)
-
PR Newswire09/21 09:31
-
Yahoo09/13 16:38
-
Yahoo09/12 11:17
-
Yahoo09/12 07:54
-
Yahoo09/06 16:04
-
Yahoo09/02 10:11
-
PR Newswire08/31 07:50
-
Yahoo08/26 16:04
-
SA Breaking News08/26 07:15
-
Yahoo08/25 16:04
View All Events
MACK Events
| Date | Type | Description |
|---|---|---|
| 08/04/2016 16:30 EDT | Misc | Merrimack Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2016 |
| 08/04/2016 | Earnings | Merrimack Pharmaceuticals Inc Second Quarter Earnings in 2016 Release |
| 06/14/2016 | Misc | Merrimack Pharmaceuticals Inc Annual General Meeting in 2015 |
| 11/09/2015 16:30 EST | Misc | Merrimack Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2015 |
| 11/09/2015 | Earnings | Merrimack Pharmaceuticals Inc Third Quarter Earnings in 2015 Release |
MACK Fundamentals
Income Statement View Statement
MACK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.merrimack.com
- Investor Relations URL: http://investors.merrimackpharma.com/
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: August 04, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Merrimack Pharmaceuticals Inc is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer.
MACK Comparables
EditMACK Excel Add-In Codes
- Name: =YCI("MACK","name")
- Description: =YCI("MACK","description")
- Sector: =YCI("MACK","sector")
- Industry: =YCI("MACK","industry")
- Est. Current Fiscal Year End: =YCI("MACK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MACK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MACK Tweets Stocktwits
Advertisement